Parallel Advisors’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $13.6K | Sell |
777
-3,077
| -80% | -$61.1K | ﹤0.01% | 2625 |
|
|
2025
Q4 | $75.7K | Buy |
3,854
+3,589
| +1,354% | +$74.5K | ﹤0.01% | 1620 |
|
|
2025
Q3 | $7.3K | Sell |
265
-43
| -14% | -$1.32K | ﹤0.01% | 2637 |
|
|
2025
Q2 | $9.4K | Sell |
308
-1,093
| -78% | -$31K | ﹤0.01% | 2502 |
|
|
2025
Q1 | $37.8K | Buy |
1,401
+1,384
| +8,141% | +$43.8K | ﹤0.01% | 1801 |
|
|
2024
Q4 | $610 | Sell |
17
-463
| -96% | -$17.3K | ﹤0.01% | 3187 |
|
|
2024
Q3 | $18.2K | Buy |
480
+269
| +127% | +$11.1K | ﹤0.01% | 2152 |
|
|
2024
Q2 | $9.55K | Sell |
211
-412
| -66% | -$19K | ﹤0.01% | 2338 |
|
|
2024
Q1 | $30.2K | Buy |
623
+25
| +4% | +$1.22K | ﹤0.01% | 1755 |
|
|
2023
Q4 | $32.1K | Sell |
598
-185
| -24% | -$9.36K | ﹤0.01% | 1664 |
|
|
2023
Q3 | $45.9K | Sell |
783
-138
| -15% | -$8.63K | ﹤0.01% | 1434 |
|
|
2023
Q2 | $58.1K | Buy |
921
+134
| +17% | +$8.53K | ﹤0.01% | 1330 |
|
|
2023
Q1 | $49.5K | Buy |
787
+254
| +48% | +$15.2K | ﹤0.01% | 1372 |
|
|
2022
Q4 | $28.4K | Buy |
533
+369
| +225% | +$20K | ﹤0.01% | 1555 |
|
|
2022
Q3 | $9K | Sell |
164
-522
| -76% | -$34.5K | ﹤0.01% | 2049 |
|
|
2022
Q2 | $50K | Buy |
686
+647
| +1,659% | +$48.2K | ﹤0.01% | 1259 |
|
|
2022
Q1 | $3K | Sell |
39
-57
| -59% | -$5.14K | ﹤0.01% | 2514 |
|
|
2021
Q4 | $10K | Buy |
96
+20
| +26% | +$2K | ﹤0.01% | 2130 |
|
|
2021
Q3 | $7K | Buy |
76
+56
| +280% | +$5.39K | ﹤0.01% | 2254 |
|
|
2021
Q2 | $2K | Hold |
20
| – | – | ﹤0.01% | 2626 |
|
|
2021
Q1 | $2K | Hold |
20
| – | – | ﹤0.01% | 2530 |
|
|
2020
Q4 | $2K | Hold |
20
| – | – | ﹤0.01% | 2360 |
|
|
2020
Q3 | $1K | Hold |
20
| – | – | ﹤0.01% | 2502 |
|
|
2020
Q2 | $1K | Hold |
20
| – | – | ﹤0.01% | 2380 |
|
|
2020
Q1 | $1K | Buy |
+20
| New | +$1.39K | ﹤0.01% | 2338 |
|
|
2019
Q3 | – | Sell |
-57
| Closed | -$5K | – | 2496 |
|
|
2019
Q2 | $5K | Buy |
+57
| New | +$4.52K | ﹤0.01% | 1851 |
|
|
2019
Q1 | – | Sell |
-19
| Closed | -$2K | – | 2400 |
|
|
2018
Q4 | $2K | Buy |
+19
| New | +$2.2K | ﹤0.01% | 1922 |
|
|
2017
Q3 | – | Sell |
-50
| Closed | -$3K | – | 2218 |
|
|
2017
Q2 | $3K | Hold |
50
| – | – | ﹤0.01% | 1795 |
|
|
2017
Q1 | $3K | Hold |
50
| – | – | ﹤0.01% | 1706 |
|
|
2016
Q4 | $3K | Buy |
+50
| New | +$3.26K | ﹤0.01% | 1556 |
|
Other funds holding USNA
NCM
VCM
VPM
Parallel Advisors's USNA Position: Q1 2026 in Review
Parallel Advisors reduced its Usana Health Sciences (USNA) stake by 80% in Q1 2026, selling an estimated $61.1K and leaving 777 shares worth $13.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2625.
Parallel Advisors first reported a position in USNA in Q4 2016 and has held it in 30 quarters since. The position peaked at $75.7K in Q4 2025. 139 funds tracked by Wall St. Rank hold USNA as of Q1 2026.
- Parallel Advisors held 777 shares of Usana Health Sciences worth $13.6K as of Q1 2026.
- Parallel Advisors sold 3,077 Usana Health Sciences shares in Q1 2026, an estimated $61.1K.
- Usana Health Sciences made up ﹤0.01% of Parallel Advisors's portfolio in Q1 2026, its #2625 holding.
- Parallel Advisors first reported a position in Usana Health Sciences in Q4 2016 and has held it in 30 quarters since.
- Parallel Advisors's Usana Health Sciences position peaked at $75.7K in Q4 2025.
- 139 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2026.
Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.